SLC2A1 and cancer: To solve this problem, Morales et al. engineered carbohydrate-cNDI conjugates (carb-cNDIs) that entered into cancer cells taking advantage of the overexpressed glucose transporter (GLUT) (compounds 30–32, Table 1) [57].